Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Robot-Assisted Gait Training vs NMES in Parkinson's Disease

Trial N/A Recruiting May 14, 2026

Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Trial Phase 4 Completed May 13, 2026

Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)

Trial Phase 4 Completed May 13, 2026

China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration

Trial N/A Enrolling by invitation May 13, 2026

Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease

Trial Phase 2 Completed May 13, 2026

Personalized Real-Time DBS and PD Mechanisms

Trial Phase 4 Recruiting May 13, 2026

Phase 1/2a Study of ANPD001 in Parkinson Disease

Trial Phase 1 Enrolling by invitation May 13, 2026

Dopaminergic restauratIon by intraVEntriculaire Administration

Trial Phase 1 Completed May 13, 2026

Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation

Trial N/A Completed May 13, 2026

Cognitive Phenotypes in Parkinson's Disease

Trial N/A Completed May 13, 2026

Rhythmic Auditory Stimulation on Upper-limb Movements in PD Patients

Trial N/A Completed May 13, 2026

Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes

Trial N/A Completed May 13, 2026

Motor and Cognitive Telerehabilitation in a Virtual Environment in Patients With Post-stroke Sequelae and Parkinson's Disease

Trial N/A Not yet recruiting May 13, 2026

Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease

Trial N/A Recruiting May 12, 2026

A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With Motor Fluctuations

Trial Phase 2 Not yet recruiting May 12, 2026

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Trial Phase 2 Active, not recruiting May 12, 2026

Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease

Trial Phase 3 Completed May 12, 2026

Repurposing Lithium for Parkinson's Disease

Trial Phase 1 Completed May 12, 2026

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

Trial N/A Recruiting May 12, 2026

North American Prodromal Synucleinopathy Consortium Stage 2

Trial N/A Enrolling by invitation May 12, 2026